色情久久久av熟女人妻网站_99国精品午夜福利视频不卡_久久精品亚洲一区二区三区浴池_美女把尿囗扒开让男人添_1000部夫妻午夜免费

歡迎來到上海通蔚!

021-54845833/15800441009

品質保證 · 通蔚試劑

當前位置: 首頁 > 科研產品 > 科研抗體 > 其他抗體 > FKBP4抗原(重組蛋白)

產品中心

  • FKBP4抗原(重組蛋白)

    規(guī)格:
    價格:
    • 品牌 : 通蔚生物
    • 目錄號 : TW18645
    • 應用 : 僅供科研使用
    • 貨期 : 現(xiàn)貨
    • 規(guī)格 :1mg/100ug
  • 商品詳情
  • 參考文獻
  • 說明書下載
  • 商品評論0
  • 相關產品

中文名稱:FKBP4抗原(重組蛋白)

英文名稱: FKBP4 Antigen (Recombinant Protein)

別      名: HBI; p52; Hsp56; FKBP51; FKBP52; FKBP59; PPIase

儲      存:冷凍(-20℃)

相關類別: 抗原

概      述:

Fusion protein corresponding to a region derived from 263-459 amino acids of human FKBP4


技術規(guī)格:

Full name:

FK506 binding protein 4

Synonyms:

HBI; p52; Hsp56; FKBP51; FKBP52; FKBP59; PPIase

Swissprot:

Q02790

Gene Accession:

BC001786

Purity:

>85%, as determined by Coomassie blue stained SDS-PAGE

Expression system:

Escherichia coli

Tags:

His tag C-Terminus, GST tag N-Terminus

Background:

The protein encoded by this gene is a member of the immunophilin protein family, which play a role in immunoregulation and basic cellular processes involving protein folding and trafficking. This encoded protein is a cis-trans prolyl isomerase that binds to the immunosuppressants FK506 and rapamycin. It has high structural and functional similarity to FK506-binding protein 1A (FKBP1A), but unlike FKBP1A, this protein does not have immunosuppressant activity when complexed with FK506. It interacts with interferon regulatory factor-4 and plays an important role in immunoregulatory gene expression in B and T lymphocytes. This encoded protein is known to associate with phytanoyl-CoA alpha-hydroxylase. It can also associate with two heat shock proteins (hsp90 and hsp70) and thus may play a role in the intracellular trafficking of hetero-oligomeric forms of the steroid hormone receptors. This protein correlates strongly with adeno-associated virus type 2 vectors (AAV) resulting in a significant increase in AAV-mediated transgene expression in human cell lines. Thus this encoded protein is thought to have important implications for the optimal use of AAV vectors in human gene therapy. The human genome contains several non-transcribed pseudogenes similar to this gene.